Camena Bioscience and Constructive Bio join synthetic biology collaboration to develop plant genomics
See full press release.
All posts from the author
Camena Bioscience
Why are we TdT-free?
5/26/24 | 3 minute read
In recent years, there has been significant interest in using an enzyme called Terminal deoxynucleotidyl transferase (TdT) to produce synthetic DNA. If we're a cutting-edge DNA synthesis company, why aren't we using TdT?
Read more
The codon optimisation challenge
Life's code isn't strictly in DNA, it's also where information is translated into proteins. Consequently, changing a gene's codons can disrupt its protein function. Even the FDA think this topic is important.
Scaling cell and gene therapies with DNA synthesis
Synthetic DNA sequences with fewer constraints on sequence complexity are crucial to drive cell and gene therapies forward. Here’s why.
The nexus between climate change and healthcare
If healthcare were a country it would be the 5th largest polluter on the planet, representing 4.4% of the global total.
Personalized mRNA vaccines
As the potential of mRNA vaccines to meet a significant, unfulfilled medical demand becomes increasingly clear, we’ll need greater access to gene-length DNA far beyond what’s available right now.
Why are we TdT-free?
In recent years, there has been significant interest in using an enzyme called Terminal deoxynucleotidyl transferase (TdT) to produce synthetic DNA. If we're a cutting-edge DNA synthesis company, why aren't we using TdT?
Helping CRISPR-Cas technology unleash its potential
We all know by now that the CRISPR-Cas system is nothing short of a revolution for gene editing, but DNA synthesis can’t keep up with CRISPR.
Synthetic biology and the discovery of new medicines
Over recent years the pharmaceutical industry has gradually turned towards synthetic biology to assist with the discovery of new medicines.
100 ways to make 1 gene
To produce a synthetic gene, we first divide it up into smaller pieces of DNA that are synthesised. Genes can be thousands of base pairs long, so there are many different ways to do this.
World mental health day
Did you know that today is World Mental Health Day?
Camena Bioscience close $10m Series A financing as demand for DNA synthesis technology increases
Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has closed a $10m Series A financing round, led by Mercia.
Celebrating the 10,000 Black Interns summer programme 2023
Divina Newman and Nika Pierre joined the Camena team for 8 weeks over the summer. It was initially 6 but such was their committment to learning and contribution to ongoing projects, we asked them to stay. We're immensely proud of their accomplishments and the programme enriched the whole team. We asked Divina and Nika to share their experiences.
Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board
Following its $10 million Series A financing1 earlier in the year, the appointment forms part of the Company’s growth plans to expand commercialisation of its pioneering DNA synthesis platform, gSynth™.
Increasing talent diversity in biotechnology
Camena Bioscience signs up for two exciting initiatives, 10,000 Black Interns and In2Science.
Breaking new ground: our longest DNA construct yet
Last week marked a significant milestone for our team as we successfully delivered the longest DNA construct we've ever created—a staggering 6.5 kilobases (kb).